Press Releases
Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
SANTA FE, N.M. – 17th March 2023 – Specifica, a Q2 Solutions company focused on innovative in vitro antibody libraries and discovery tools...
March 13, 2023
Press Releases
Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
SANTA FE, N.M.--(BUSINESS WIRE)--Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under…
June 02, 2022
Press Releases
Specifica is pleased to announce the United States Patent and Trademark Office has granted two patents to Specifica for its innovative Generation 3 Antibody Discovery Platform
SANTA FE, NM – (BUSINESS WIRE) – Mar. 10, 2022 – Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the…
March 10, 2022
Press Releases
Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications
SANTA FE, NM – (BUSINESS WIRE) – Jan. 24, 2022 – Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the…
January 28, 2022
Press Releases
OpenEye Scientific and Specifica Partner to Launch Orion® Antibody Discovery Suite incorporating AbXtract™
Next Generation Sequencing Software to Help Antibody Engineers, Bioinformaticians Uncover Potential Antibody Therapeutics SANTA FE, N.M. – December 2, 2021 – OpenEye Scientific and Specifica, Inc., today announced they are…
December 02, 2021
Press Releases
Specifica Delivers Antibody Platform to UCB to Speed up Development of New Therapeutics
Santa Fe, New Mexico, December 1, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has delivered an exclusive antibody library platform to UCB, a global biopharmaceutical…
December 01, 2020
Press Releases
Specifica Partners With Scholar Rock to Design and Create Antibody Display Library for Therapeutic Biologic Discovery
Santa Fe, New Mexico, August 5, 2020 — Specifica, a company revolutionizing antibody discovery, today announced that it has designed and created an exclusive antibody display library in collaboration with…
August 05, 2020
Press Releases
Specifica Announces Antibody Discovery Platform Transfer to Bayer
Company’s Generation 3 Antibody Platform Delivers High-Affinity, Drug-Like Antibody Candidates Well Designed to Facilitate the Development of High-Quality Therapeutics Santa Fe, New Mexico, May 12, 2020 — Specifica, a leading…
May 12, 2020
